...
首页> 外文期刊>JPEN. Journal of parenteral and enteral nutrition. >Clinical Decision Support System‐Assisted Pharmacy Intervention Reduces Feeding Tube–Related Medication Errors in Hospitalized Patients: A Focus on Medication Suitable for Feeding‐Tube Administration
【24h】

Clinical Decision Support System‐Assisted Pharmacy Intervention Reduces Feeding Tube–Related Medication Errors in Hospitalized Patients: A Focus on Medication Suitable for Feeding‐Tube Administration

机译:临床决策支持系统辅助药房干预减少住院患者中的饲养管相关药物误差:专注于适合饲喂管给药的药物

获取原文
           

摘要

Background Administering medication through an enteral feeding tube (FT) is a frequent cause of errors resulting in increased morbidity and cost. Studies on interventions to prevent these errors in hospitalized patients, however, are limited. Objective The objective was to study the effect of a clinical decision support system (CDSS)–assisted pharmacy intervention on the incidence of FT‐related medication errors (FTRMEs) in hospitalized patients. Methods A pre‐post intervention study was conducted between October 2014 and May 2015 in Catharina Hospital, the Netherlands. Patients who were admitted to the wards of bowel and liver disease, oncology, or neurology; using oral medication; and had an enteral FT were included. Preintervention patients were given care as usual. The intervention consisted of implementing a CDSS‐assisted pharmacy check while also implementing standard operating procedures and educating personnel. An FTRME was defined as the administration of inappropriate medication through an enteral FT. The incidence was expressed as the number of FTRMEs per medication administration. Multivariate Poisson regression was used to calculate the incidence ratio (IR) comparing both phases. Results Eighty‐one patients were included, 38 during preintervention and 43 during the intervention phase. Incidence of FTRMEs in the preintervention phase was 0.15 (95% CI, 0.07–0.23) vs 0.02 (95% CI, 0.00–0.04) in the intervention phase, resulting in an adjusted IR of 0.13 (95% CI, 0.10–0.18). Discussion Incidence of FTRMEs, as well as the IR, is comparable to previous studies. Conclusion The intervention resulted in a substantial reduction in the incidence of FTRMEs.
机译:背景技术通过肠内喂食管(FT)施用药物是误差的常见原因,导致发病率增加和成本增加。然而,有限于治疗住院患者患者的干预措施的研究有限。具体目标是研究临床决策支持系统(CDSS)的药房干预对住院患者FT相关药物误差(FTRMES)发病率的影响。方法在2014年10月和2015年5月在荷兰Catharina医院之间进行了职前干预研究。入院的患者患有肠和肝病病房,肿瘤学或神经学;使用口服药物;并纳入了恩式英国人。优先服用患者。干预包括实施CDSS辅助药物检查,同时还实施标准的操作程序和教育人员。 FTRME被定义为通过肠内英尺的不恰当药物的给药。该发病率表示为每种药物施用的孢子率的数量。多元泊松回归用于计算两相的入射率(IR)。结果包括八十一名患者,在介入期间38例,干预阶段期间43例。在干预阶段,预领取阶段中FTRMES的发生率为0.15(95%CI,0.07-0.23),导致0.13的调节IR(95%CI,0.10-0.18) 。讨论FTRMES以及IR的发病率与以前的研究相当。结论干预导致FTRMES发病率大幅减少。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号